Microsoft Investment Quality Review (MSFT)

Data timestamp: 2026-08-03 22:13 UTC
Quality score: 81/100
Valuation position: current price/base FV 6.24
Final signal: WATCHLIST

Core Conclusion

Microsoft is a strong watchlist company but not a buy. USD487.65 is 6.24x base FV of USD78.09 and 7.83x conservative FV of USD62.26. The company has exceptional strategic assets, but the current price is far above normalized FCF value.

Business Breakdown

Five-year revenue CAGR is 13.7%, with latest-year revenue of USD281.72bn. Cloud, SaaS, enterprise distribution, and AI integration support quality, while AI capex and valuation discipline are the gating issues.

Business Quality

The 81/100 score reflects high profitability, durable enterprise demand, and cash generation. Latest-year FCF was USD71.61bn. Five-year average ROE was 38.1%; ROIC was not reliably disclosed from structured fields.

Financial Audit

Fiscal 2025 revenue was USD281.72bn, net profit USD101.83bn, operating cash flow USD136.16bn, capex USD64.55bn, and FCF USD71.61bn. Five-year FCF/net income was 0.72 and OCF/net income was 1.31. Latest net debt was USD75.25bn.

Valuation

The conservative case uses USD67.46bn normalized FCF, -0.3% growth, and 8.0x, producing USD62.26 per share. The base case uses 0.7% growth and 9.7x, producing USD78.09. The optimistic case uses 2.2% growth and 13.1x, producing USD108.58. Current price exceeds all scenarios.

Buy And Tracking Discipline

The action is watch. A buy requires price/base FV below 0.70, quality above 75, stable FCF after AI infrastructure spend, durable cloud margins, and no deterioration in leverage or capital returns.

Risk Review

Risks include AI capex intensity, cloud competition, regulatory action, margin pressure, net debt, and overvaluation. If FCF conversion weakens or buybacks occur at value-dilutive prices, FV should be reduced.

Data Sources

The memo relies on public market and financial data, company filings or investor-relations materials, public US Treasury yield data, and public FX data where applicable. This is research only, not personalized investment advice.